Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Quantum Biopharma ( (TSE:QNTM) ).
Quantum BioPharma’s licensee, Unbuzzd Wellness Inc., is hosting an investor webinar to discuss its innovative beverage, unbuzzd, which accelerates alcohol metabolism and reduces hangover symptoms. The webinar will cover investment opportunities and strategies for expanding sales. Unbuzzd’s recent clinical trial demonstrated significant improvements in alcohol metabolism and hangover relief, positioning it as a promising product in the wellness market.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative biotech solutions for neurodegenerative, metabolic, and alcohol misuse disorders. The company has a range of drug candidates in various development stages. Its licensee, Unbuzzd Wellness Inc., specializes in wellness and recovery supplements, offering a scientifically-proven beverage that accelerates alcohol metabolism and reduces hangover symptoms.
Average Trading Volume: 5,730
Technical Sentiment Signal: Hold
Current Market Cap: C$83.95M
See more data about QNTM stock on TipRanks’ Stock Analysis page.